692
A.A. Esenpınar et al. / Spectrochimica Acta Part A 81 (2011) 690–697
2.5. Synthesis
C 66.18; H 4.12; N 5.32%. Found: C 66.22; H 4.14; N 5.30%. MS
(MALDI-TOF, 2,5-dihydroxybenzoic acid as matrix): m/z 2105 [M]+.
2.5.1.
6,7-[(12-Crown-4)-3-[p-(3,4-dicyanophenoxy)phenyl]coumarin
(1)
2.5.4. 1(4),8(11),15(18),22(25)-Tetrakis[6,7-(12-crown-4)-3-(4-
oxyphenyl)coumarin)]-phthalocyaninato zinc(II) complex
(4)
6,7-Dihydroxy-3-[p-(3,4-dicyanophenoxy)phenyl]coumarin
(1.00 g, 2.50 mmol) and triethylenglycol ditosylate (1.26 g,
2.50 mmol) were dissolved in dry CH3CN (150 ml) under nitrogen
atmosphere and anhydrous Na2CO3 (0.53 g, 5 mmol) was added.
This mixture was stirred for 7 days at 85–90 ◦C and then sol-
vent was evaporated in vacuum. Diluted HCl was added to the
residue and the mixture was extracted with CHCl3 (4 × 30 ml).
The combined organic extracts were washed with water, dried
over CaCl2 and evaporated in vacuum. Crude product was purified
by column chromatography passing through silica gel 60 with
chloroform as eluent and pure chromenone crown ether was
obtained. The compound is soluble in ethanol, methanol, tetrahy-
drofuran (THF), chloroform (CHCl3), dichloromethane (CH2Cl2),
dimethylformamide (DMF) and dimethylsulfoxide (DMSO). Yield:
0.10 g (8%). m.p.: 134–138 ◦C. IR ꢃ(cm−1): 3100–3050 (Ar-CH),
2980–2800 (aliphatic CH), 2200 (C N), 1705 (C O), 1600 (Ar C C),
1245 (Ar-O-Ar). 1H NMR (DMSO-d6, 500 MHz, ı ppm): 8.32 (s, 1H,
lactone-H3), 8.19 (d, 1H, Ar-H6), 8.14 (d, J = 8 Hz, 1H, Ar-H8), 7.86
(dd, J = 8 Hz, 2H, Ar-H4), 7.47 (d, J = 8 Hz, 1H, Ar-H7), 7.30 (d, J = 8 Hz,
2H, Ar-H5), 7.21 (s, 1H, Ar-H1), 7.12 (s, 1H, Ar-H2), 4.18 (m, 4H,
OCH2), 3.80 (m, 4H, OCH2), 3.71 (m, 4H, OCH2). UV–Vis ꢄmax (nm)
(log ε) (THF) (1 × 10−5 M): 363 (5.32). Anal. calcd. for C29H22N2O7:
C 68.23; H 4.34; N 5.49%. Found: C 68.19; H 4.27; N 5.51%. MS
(MALDI-TOF): m/z 510.8 [M]+.
Synthesis and purification were as outlined for 3 except
6,7-[(12-crown-4)-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin
(2) was employed instead of 6,7-[(12-crown-4)-3-[p-(3,4-
dicyanophenoxy)phenyl]coumarin
(1).
The
amounts
of
the reagents employed were: 6,7-[(12-crown-4)-3-[p-(2,3-
dicyanophenoxy)phenyl]coumarin (2) (0.05 g, 0.098 mmol),
Zn(AcO)2 (0.0054 g, 0.024 mmol) dry DMAE (2 ml). The compound
4 is soluble in DMF and DMSO. Yield: 0.045 g (80%), m.p.: > 300 ◦C.
IR ꢃ(cm−1): 3053 (Ar-H), 2918–2861 (aliphatic-CH), 1717 (C
O
lactone), 1614–1569 (C C), 1246 (Ar-O-Ar). UV–Vis ꢄmax (nm)
(log ε) (DMSO) (1 × 10−5 M): 699 (4.83), 669 (4,12), 363 (4.82).
Anal. calcd. for C116H86N8O28Zn: C 66.18; H 4.12; N 5.32%. Found:
C 66.15; H 4.12; N 5.28%. MS (MALDI-TOF, 2,5-dihydroxybenzoic
acid as matrix): m/z 2105 [M]+, 2197 [M+4Na]+.
3. Result and discussion
3.1. Synthesis and characterization
6,7-Dihydroxy-3-[p-(3,4-dicyanophenoxy)phenyl]coumarin
and 6,7-dihydroxy-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin
CH3CN, respectively. The crude products were purified by column
chromatography over silica gel using CHCl3 as eluent and the
chromenone crown ether compounds were obtained in 8% yield
for 1 and in 10% yield for 2 (Scheme 1). The ZnPc complexes show
good solubility in solvents such as DMF and DMSO. The novel
compounds have been characterized by elemental analysis IR, 1H
NMR and MALDI-MS spectroscopy.
2.5.2.
6,7-[(12-Crown-4)-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin
(2)
Synthesis and purification were as outlined for 1 except
6,7-dihydroxy-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin was
employed instead of 6,7-dihydroxy-3-[p-(3,4-dicyanophenoxy)
phenyl]coumarin. The amounts of the reagents employed were:
6,7-dihydroxy-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin
(1.00 g, 2.50 mmol), triethylenglycol ditosylate (1.26 g, 2.50 mmol),
anhydrous Na2CO3 (0.53 g, 5 mmol) in DMF (150 ml). Yield: 0.13 g
(10%). m.p.: 180–184 ◦C. IR ꢃ(cm−1): 3055 (Ar-CH), 2928–2864
(aliphatic CH), 2228 (C≡N), 1714 (C O), 1619–1570 (Ar C C),
1242 (Ar-O-Ar). 1H NMR (DMSO-d6, 500 MHz, ı ppm): 8.28 (s, 1H,
lakton-H3), 7.98 (d, J = 8 Hz, 2H, Ar-H4), 7.92 (t, 1H, Ar-H7), 7.78
(d, J = 8 Hz, 1H, Ar-H6), 7.55 (d, J = 8 Hz, 1H, Ar-H8), 7.41 (d, J = 8 Hz,
2H, Ar-H5), 7.20 (s, 1H, Ar-H1), 7.17 (s, 1H, Ar-H2), 4.11 (m, 4H,
OCH2), 3.82 (m, 4H, OCH2), 3.55 (m, 4H, OCH2). UV–Vis ꢄmax (nm)
(log ε) (THF) (1 × 10−5 M): 355 (3.97), 320 (3.84). Anal. calcd. for
The IR spectra showed two vibration peaks at ca.
2980–2800 cm−1 for compound
1
and 2982–2864 cm−1 for
compound 2 due to aliphatic C–H stretching frequency. The char-
acteristic vibrational peaks of the carbonyl (C O) was appeared in
the region 1705–1714 cm−1. The vibration peaks corresponding to
C–O–C ether chain was appeared in the range 1245–1242 cm−1
.
The characteristic C≡N peaks were also showed at 2220 cm−1 for
compound 1 and 2228 cm−1 for compound 2.
The 1H NMR spectra showed the expected peak resonances
and peak integrals due to the protons of chromenone crown ether
derivatives (1 and 2) in DMSO-d6. The 1H NMR spectra of 1 and 2
showed characteristic signals for etheral (–O–CH2–CH2–O–) pro-
tons at ı 3.71–4.18 ppm for compound 1 and 3.55–4.11 ppm for
compound 2 as multiplets. The singlet peak at ı 8.32 ppm for com-
pound 1 and 8.28 ppm for compound 2 indicated the presence of
lacton protons. In addition, the chemical shifts of the aromatic pro-
tons were observed at between 7.12–8.19 ppm and 7.17–8.28 ppm
for compounds 1 and 2, respectively.
C
29H22N2O7: C 68.23; H 4.34; N 5.49%. Found: C 68.11; H 4.17; N
5.49%. MS (MALDI-TOF): m/z 510.1 [M]+, 511.2 [M+1]+.
2.5.3. 2(3),9(10),16(17),23(24)-Tetrakis[6,7-(12-crown-4)-3-(4-
oxyphenyl)coumarin)]-phthalocyaninato zinc(II) complex
(3)
6,7-[(12-Crown-4)-3-[p-(3,4-dicyanophenoxy)phenyl]coumarin
(1) (0.05 g, 0.098 mmol), Zn(AcO)2 (0.0054 g, 0.024 mmol) and dry
N,N-dimethylamino ethanol (DMAE) (2 ml) were refluxed with
stirring under N2 atmosphere for 24 h. After cooling to room
temperature, the mixture was treated with methanol, and then
the precipitated product was filtered off; washed with water,
methanol, ethanol, acetonitrile, ethyl acetate, aceton, acetic acid
and diethyl ether. The compound 3 is soluble in DMF and DMSO.
Yield: 0.041 g (79%), m.p.: > 300 ◦C. IR ꢃ(cm−1): 3100–3050 (Ar-H),
2985–2800 (aliphatic-CH), 1725 (C O lactone), 1625 (C C), 1230
(Ar-O-Ar). UV–Vis ꢄmax (nm) (log ε) (DMSO) (1 × 10−5 M): 679
(5.02), 648 (4.43), 355 (5.01). Anal. calcd. for C116H86N8O28Zn:
2(3),9(10),16(17),23(24)-Tetrakis[6,7-(12-crown-4)-3-
(4-oxyphenyl)coumarin)]-phthalocyaninato
zinc
(3)
and
1(4),8(11),15(18),22(25)-tetrakis[6,7-(12-crown-4)-3-(4-
oxyphenyl)coumarin)]-phthalocyaninato zinc (4) complexes
have been prepared by cyclotetramerization of novel 6,7-[(12-
crown-4)-3-[p-(3,4-dicyanophenoxy)phenyl] coumarin (1) and
6,7-[(12-crown-4)-3-[p-(2,3-dicyanophenoxy)phenyl]coumarin
(2), respectively. Cyclotetramerization of the dinitril compounds
(1 and 2) to the ZnPc complexes (3 and 4) was confirmed by the
disappearance of the sharp C≡N vibration at 2200 and 2228 cm−1
for compounds 1 and 2, respectively. The IR spectra showed
characteristic vibrational peaks at 3050 cm−1 for complex 3 and